Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

The Amazon juggernaut finally comes into view

Community pharmacy may believe there is no competition for monitored dosage systems (MDS) currently supplied at a loss. But a glance in the rear-view mirror reveals a juggernaut coming into view: Amazon has just acquired PillPack, an online pharmacy that operates in 49 US states and focuses on supply to customers on multiple medications.

Shares in Walgreens Boots Alliance, CVS Health and McKesson fell 7–10% in response, a signal of how seriously investors take the threat of Amazon to conventional pharmacy distribution and wholesaling providers. If the acquisition is approved, Amazon, whose Prime subscription service has 100 million subscribers, could, in time, have the capability to supply medicines to the homes of customers well beyond the United States[1]. High MDS volumes could be supplied by Amazon with far greater efficiency and consequently at lower cost than now — an attractive proposition for national and local NHS payers. In 2015–2016, 24% of adults living in their own homes in England were taking three or more medicines[2] — a huge potential market for MDS.

Eileen Neilson, director, Willow Consulting (London) Ltd.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205137

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.